Financhill
Buy
63

DRUG.CX Quote, Financials, Valuation and Earnings

Last price:
$116.00
Seasonality move :
-25.59%
Day range:
$112.44 - $116.00
52-week range:
$33.01 - $131.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
15.80x
Volume:
800
Avg. volume:
1.4K
1-year change:
109.44%
Market cap:
$819.2M
Revenue:
--
EPS (TTM):
-$1.32
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $6K $72.4K $73.4K
Gross Profit -- -- -$6K -$72.4K -$73.4K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $193.6K $6.3M $12.2M $5M $1.2M
Selling, General & Admin $286.8K $1M $1M $398.2K $305.6K
Other Inc / (Exp) -- $154.1K $10.2K $14.2K -$9.3K
Operating Expenses $480.4K $8.8M $15M $7.3M $2.7M
Operating Income -$480.4K -$8.8M -$15M -$7.4M -$2.8M
 
Net Interest Expenses -- -- -- $19.8K $8.9K
EBT. Incl. Unusual Items -$480.4K -$8.7M -$15M -$7.4M -$2.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$480.4K -$8.7M -$15M -$7.4M -$2.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$480.4K -$8.7M -$15M -$7.4M -$2.8M
 
Basic EPS (Cont. Ops) -$0.38 -$4.82 -$6.06 -$1.98 -$0.65
Diluted EPS (Cont. Ops) -$0.38 -$4.82 -$6.06 -$1.98 -$0.65
Weighted Average Basic Share $1.3M $1.8M $2.5M $3.7M $4.3M
Weighted Average Diluted Share $1.3M $1.8M $2.5M $3.7M $4.3M
 
EBITDA -$480.4K -$8.8M -$15M -$7.3M -$2.7M
EBIT -$480.4K -$8.8M -$15M -$7.4M -$2.8M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$480.4K -$8.8M -$15M -$7.4M -$2.8M
Operating Income (Adjusted) -$480.4K -$8.8M -$15M -$7.4M -$2.8M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $18.1K $18.1K $15.8K
Gross Profit -- -- -$18.1K -$18.1K -$15.8K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.7M $2.1M $1.1M -$566.7K $2.7M
Selling, General & Admin $526.8K $170.9K $159.1K $81.2K $278.2K
Other Inc / (Exp) $114.1K $4.3K -$10.1K -$19.8K --
Operating Expenses $3.6M $2.7M $1.4M -$254.1K $3.3M
Operating Income -$3.6M -$2.7M -$1.4M $236K -$3.3M
 
Net Interest Expenses -- -- $4.6K $1.2K $8.5K
EBT. Incl. Unusual Items -$3.5M -$2.7M -$1.5M $229.9K -$5.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- -$257.9K
Net Income to Company -$3.5M -$2.7M -$1.5M $229.9K -$5.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$3.5M -$2.7M -$1.5M $229.9K -$5.2M
 
Basic EPS (Cont. Ops) -$1.49 -$1.12 -$0.39 $0.05 -$0.74
Diluted EPS (Cont. Ops) -$1.49 -$1.12 -$0.39 $0.05 -$0.74
Weighted Average Basic Share $2.4M $2.4M $3.8M $4.5M $7.1M
Weighted Average Diluted Share $2.4M $2.4M $3.8M $4.6M $7.1M
 
EBITDA -$3.6M -$2.7M -$1.4M $254.1K -$3.3M
EBIT -$3.6M -$2.7M -$1.4M $236K -$3.3M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$3.6M -$2.7M -$1.4M $236K -$3.3M
Operating Income (Adjusted) -$3.6M -$2.7M -$1.4M $236K -$3.3M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $60.4K $72.4K $78.9K
Gross Profit -- -- -$60.4K -$72.4K -$78.9K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $3.9M $11.8M $6.4M $1.9M $6.7M
Selling, General & Admin $805.8K $1.1M $584K $279.6K $850.4K
Other Inc / (Exp) $54.5K $59.6K $6.4K $36.8K --
Operating Expenses $5.9M $14.9M $8.7M $3.5M $9M
Operating Income -$5.9M -$14.9M -$8.8M -$3.6M -$9M
 
Net Interest Expenses -- -- $9.9K $10.1K $24.7K
EBT. Incl. Unusual Items -$5.9M -$14.9M -$8.8M -$3.6M -$9.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- -$257.9K
Net Income to Company -$6.2M -$14.9M -$8.8M -$3.6M -$8.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$5.9M -$14.9M -$8.8M -$3.6M -$8.9M
 
Basic EPS (Cont. Ops) -$2.91 -$6.28 -$2.57 -$0.92 -$1.32
Diluted EPS (Cont. Ops) -$2.91 -$6.28 -$2.57 -$0.92 -$1.32
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$5.9M -$14.9M -$8.7M -$3.5M -$9M
EBIT -$5.9M -$14.9M -$8.8M -$3.6M -$9M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$5.9M -$14.9M -$8.8M -$3.6M -$9M
Operating Income (Adjusted) -$5.9M -$14.9M -$8.8M -$3.6M -$9M
Period Ending 2022-06-30 2023-06-30 2024-06-30 2025-06-30 2026-06-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $54.3K $54.3K $59.8K --
Gross Profit -- -$54.3K -$54.3K -$59.8K --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $9.6M $3.9M $764K $6.3M --
Selling, General & Admin $853.6K $407.5K $243K $797K --
Other Inc / (Exp) -$40K -$43.7K -$21.2K $1.6M --
Operating Expenses $12M $5.7M $2M $8.2M --
Operating Income -$12M -$5.8M -$2M -$8.3M --
 
Net Interest Expenses -- $9.9K $6.3K $22.1K --
EBT. Incl. Unusual Items -$12M -$5.8M -$2M -$8.4M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -$257.9K --
Net Income to Company -$12M -$5.8M -$2M -$8.1M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$12M -$5.8M -$2M -$8.1M --
 
Basic EPS (Cont. Ops) -$5.07 -$1.58 -$0.52 -$1.15 --
Diluted EPS (Cont. Ops) -$5.07 -$1.58 -$0.52 -$1.15 --
Weighted Average Basic Share $7.1M $11.1M $12.8M $20.3M --
Weighted Average Diluted Share $7.1M $11.1M $13M $20.8M --
 
EBITDA -$12M -$5.7M -$2M -$8.2M --
EBIT -$12M -$5.8M -$2M -$8.3M --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$12M -$5.8M -$2M -$8.3M --
Operating Income (Adjusted) -$12M -$5.8M -$2M -$8.3M --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $799.9K $19.8M $11.6M $6.7M $5.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $78.3K $168.2K $164.4K $27.7K $216.6K
Other Current Assets -- -- -- -- --
Total Current Assets $878.2K $20M $11.9M $6.8M $6M
 
Property Plant And Equipment -- -- $138.9K $66.4K $117.7K
Long-Term Investments $1K $33.7K -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $881.2K $20.1M $12.1M $6.9M $6.1M
 
Accounts Payable -- -- -- -- --
Accrued Expenses $12.5K $42K $158.2K $25K $41.8K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $67.9K $73.6K $79.4K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $150.9K $638.6K $1.5M $280.9K $528.7K
 
Long-Term Debt -- -- $72K -- $39.6K
Capital Leases -- -- -- -- --
Total Liabilities $150.9K $638.6K $1.5M $280.9K $568.3K
 
Common Stock $980.7K $27.1M $32.2M $33.9M $35.4M
Other Common Equity Adj -- -- -- -- --
Common Equity $730.3K $19.4M $10.5M $6.6M $5.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $730.3K $19.4M $10.5M $6.6M $5.5M
 
Total Liabilities and Equity $881.2K $20.1M $12.1M $6.9M $6.1M
Cash and Short Terms $799.9K $19.8M $11.6M $6.7M $5.7M
Total Debt -- -- $139.9K $73.5K $119K
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Cash and Equivalents $22M $8.6M $8.1M $6.2M $51.4M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $128.1K $80.3K $141.7K $58.3K $708.4K
Other Current Assets -- -- -- -- --
Total Current Assets $22.2M $8.8M $8.4M $6.3M $52.4M
 
Property Plant And Equipment -- -- $84.5K $12.1K $129K
Long-Term Investments $33.7K -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- $2K -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $22.2M $8.8M $8.5M $6.3M $52.5M
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- $15K --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $77.4K $14K --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $322.9K $385.3K $720.8K $178.6K $605K
 
Long-Term Debt -- -- $14K -- $62.8K
Capital Leases -- -- -- -- --
Total Liabilities $322.9K $385.3K $734.8K $178.6K $667.8K
 
Common Stock $27M $27.2M $33.9M $35M $89.9M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $21.9M $8.4M $7.7M $6.1M $51.8M
 
Total Liabilities and Equity $22.2M $8.8M $8.5M $6.3M $52.5M
Cash and Short Terms $22M $8.6M $8.1M $6.2M $51.4M
Total Debt -- -- $91.4K $14K $141K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$480.4K -$8.7M -$15M -$7.4M -$2.8M
Depreciation & Amoritzation -- -- $6K $72.4K $73.4K
Stock-Based Compensation $161.3K $880.6K $875.1K $1.2M $839.8K
Change in Accounts Receivable -- -$110.1K -$45.6K $118.8K -$13.2K
Change in Inventories -- -- -- -- --
Cash From Operations -$288.4K -$7.3M -$13.6M -$7M -$1.9M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -$7.2K -$86.1K -$89.7K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$1.8M -$800K -$27K --
Cash From Financing $1M $26.1M $5.2M $2.2M $810.6K
 
Beginning Cash (CF) $799.9K $19.7M $11.5M $6.7M $5.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $719.9K $19M -$8.1M -$4.9M -$1M
Ending Cash (CF) $1.5M $38.9M $3.7M $1.7M $4.6M
 
Levered Free Cash Flow -$288.4K -$7.3M -$13.6M -$7M -$1.9M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders -$3.5M -$2.7M -$1.5M $229.9K -$5.2M
Depreciation & Amoritzation -- -- $18.1K $18.1K $15.8K
Stock-Based Compensation $260.8K $293.4K $237.5K $183.9K $1.3M
Change in Accounts Receivable -$41.7K $112K -$70.3K $536K -$39.1K
Change in Inventories -- -- -- -- --
Cash From Operations -$3M -$2.9M -$1.7M $240.2K -$3.5M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -$21.5K -$22K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$623.4K -- -- -- --
Cash From Financing -$545.6K $12K -$21.5K -$22K -$16.9K
 
Beginning Cash (CF) $21.9M $8.6M $8M $6.1M $51.3M
Foreign Exchange Rate Adjustment $75.3K $23K $130.5K $39.6K -$771.6K
Additions / Reductions -$3.4M -$2.8M -$1.5M $257.8K -$4.3M
Ending Cash (CF) $18.6M $5.8M $6.6M $6.4M $46.2M
 
Levered Free Cash Flow -$3M -$2.9M -$1.7M $240.2K -$3.5M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders -$6.2M -$14.9M -$8.8M -$3.6M -$8.9M
Depreciation & Amoritzation -- -- $60.4K $72.4K $78.9K
Stock-Based Compensation $665.4K $1.2M $781.5K $1M $2.3M
Change in Accounts Receivable -$78K $13.5K -$39.2K $86.4K -$255.4K
Change in Inventories -- -- -- -- --
Cash From Operations -$5.1M -$13.8M -$8M -$2.6M -$7.9M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$32K -$39.6K -$87.5K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$860.6K -- --
Cash From Financing $27M $122.2K $7.3M $812.5K $52.2M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $21.9M -$13.4M -$510.2K -$1.9M $45.2M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$5.1M -$13.8M -$8M -$2.6M -$7.9M
Period Ending 2022-06-30 2023-06-30 2024-06-30 2025-06-30 2026-06-30
Net Income to Stockholders -$12M -$5.8M -$2M -$8.1M --
Depreciation & Amoritzation -- $54.3K $54.3K $59.8K --
Stock-Based Compensation $845.1K $751.6K $629.4K $2.1M --
Change in Accounts Receivable $45.8K $52.1K $19.7K -$222.4K --
Change in Inventories -- -- -- -- --
Cash From Operations -$11.5M -$5.8M -$1.4M -$7.4M --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$32K -$64.5K -$65.9K -$48.4K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $33.7K -$27K -- -$83.7K --
Cash From Financing $131.9K $2.2M $834K $52.2M --
 
Beginning Cash (CF) $35M $28.8M $18.6M $164.7M --
Foreign Exchange Rate Adjustment $207.4K $118.2K -$4.9K $841.7K --
Additions / Reductions -$11.1M -$3.5M -$557.7K $45.7M --
Ending Cash (CF) $24.1M $25.4M $18.1M $211.2M --
 
Levered Free Cash Flow -$11.5M -$5.8M -$1.4M -$7.4M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 4.21% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 1.01% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.58% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock